Michael Thomas Heffernan
Director at Trevi Therapeutics, Inc. (TRVI)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $596K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 17SEC | TRVITrevi Therapeutics, Inc. | Sell Plan | 18,3216,451 held (−74%) | $15.09 | $276K | -21.3% |
| Sep 17SEC | TRVITrevi Therapeutics, Inc. | Sell Plan | 1006,351 held (−2%) | $15.88 | $2K | -25.2% |
| Sep 17SEC | TRVITrevi Therapeutics, Inc. | Sell Plan | 20,9526,451 held (−76%) | $15.09 | $316K | -21.3% |
| Sep 17SEC | TRVITrevi Therapeutics, Inc. | Sell Plan | 1006,351 held (−2%) | $15.88 | $2K | -25.2% |
- Sell
Director Michael Thomas Heffernan sold $276K of TRVI at $15.09 — cuts the stake by 74%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Michael Thomas Heffernan sold $2K of TRVI at $15.88 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Michael Thomas Heffernan sold $316K of TRVI at $15.09 — cuts the stake by 76%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Michael Thomas Heffernan sold $2K of TRVI at $15.88 — pre-scheduled 10b5-1 plan sale.